APA

Bajetta E., Del Vecchio M., Nova P., Fusi A., Daponte A., Sertoli M. R., Queirolo P., Taveggia P., Bernengo M. G., Legha S. S., Formisano B. & Cascinelli N. (20060927). Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Bajetta E, Del Vecchio M, Nova P, Fusi A, Daponte A, Sertoli M R, Queirolo P, Taveggia P, Bernengo M G, Legha S S, Formisano B and Cascinelli N. 20060927. Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Bajetta E., Del Vecchio M., Nova P., Fusi A., Daponte A., Sertoli M. R., Queirolo P., Taveggia P., Bernengo M. G., Legha S. S., Formisano B. and Cascinelli N. (20060927). Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Bajetta E, Del Vecchio M, Nova P, Fusi A, Daponte A, Sertoli M R, Queirolo P, Taveggia P, Bernengo M G, Legha S S, Formisano B and Cascinelli N. Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. : Annals of oncology : official journal of the European Society for Medical Oncology. 20060927.